(Q73944620)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9400459%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

High dose bicalutamide for androgen independent prostate cancer: effect of prior hormonal therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9400459%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

1 reference

R. Joyce

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9400459

28 November 2024

M. A. Fenton

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9400459

28 November 2024

P. Rode

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9400459

28 November 2024

M. Constantine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9400459

28 November 2024

L. Gaynes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9400459

28 November 2024

G. Kolvenbag

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9400459

28 November 2024

W. DeWolf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9400459

28 November 2024

S. Balk

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9400459

28 November 2024

M. E. Taplin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9400459

28 November 2024

G. J. Bubley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9400459

28 November 2024

language of work or name

English

0 references

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9400459%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

January 1998

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9400459

full work available at URL

28 November 2024

http://api.elsevier.com/content/article/PII:S0022534701640394?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1016/S0022-5347(01)64039-4

http://api.elsevier.com/content/article/PII:S0022534701640394?httpAccept=text/plain

28 November 2024

1 reference

Crossref

https://api.crossref.org/works/10.1016/S0022-5347(01)64039-4

http://www.jurology.com/doi/pdf/10.1016/S0022-5347%2801%2964039-4

28 November 2024

1 reference

Crossref

https://api.crossref.org/works/10.1016/S0022-5347(01)64039-4

28 November 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9400459%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

159

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9400459%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9400459%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

149-153

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9400459%20AND%20SRC:MED&resulttype=core&format=json

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(01)64039-4

A study of aminoglutethemide and hydrocortisone in patients with advanced and refractory prostate carcinoma

28 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(01)64039-4

Flutamide in Hormone-Resistant Prostatic Cancer

28 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(01)64039-4

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

28 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(01)64039-4

Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer

28 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(01)64039-4

The proliferative effect of "anti-androgens" on the androgen-sensitive human prostate tumor cell line LNCaP.

28 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(01)64039-4

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

28 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(01)64039-4

Androgen Receptor Antagonist versus Agonist Activities of the Fungicide Vinclozolin Relative to Hydroxyflutamide

28 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(01)64039-4

Clinical trials in relapsed prostate cancer: defining the target

28 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(01)64039-4

Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer

28 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(01)64039-4

Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer

28 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(01)64039-4

Distant metastases from prostatic carcinoma express androgen receptor protein.

28 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(01)64039-4

Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells

28 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(01)64039-4

Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: relation to antiandrogen withdrawal syndrome

28 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(01)64039-4

Surprising activity of flutamide withdrawal, when combined with aminoglutethimide, in treatment of "hormone-refractory" prostate cancer

28 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(01)64039-4

How much can we rely on the level of prostate-specific antigen as an end point for evaluation of clinical trials? A word of caution!

28 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(01)64039-4

28 November 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9400459%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9400459%20AND%20SRC:MED&resulttype=core&format=json